Acadia Healthcare Company, Inc. has been given a Buy rating by UBS due to its strong position in the behavioral health services sector in the United States.
The company operates a variety of facilities, including acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers (CTCs), and residential treatment centers, to meet the needs of different patients.
With over 258 behavioral health facilities and 11,400 beds across 38 states and Puerto Rico, Acadia Healthcare is well-equipped to provide high-quality care.
Its acute inpatient psychiatric facilities focus on stabilizing patients who are a danger to themselves or others, while specialty treatment facilities address recovery and eating disorders.
The company also manages more than 13 CTC locations in North and South Carolina, further expanding its presence in the behavioral health landscape.